The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas

Z. G. Xu, K. Iwatsuki, N. Oyama, M. Ohtsuka, M. Satoh, S. Kikuchi, H. Akiba, F. Kaneko

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

The nasal type, extranodal natural killer or T(NK/T)-cell lymphoma is usually associated with latent Epstein-Barr virus (EBV) infection. In order to elucidate the EBV gene expression patterns in vivo, we examined eight patients with cutaneous EBV-related NK/T-cell lymphomas, including six patients with a NK-cell phenotype and two patients with a T-cell phenotype. The implication of EBV in the skin lesions was determined by the presence of EBV-DNA, EBV-encoded nuclear RNA (EBER) and a clonality of EBV-DNA fragments containing the terminal repeats. Transcripts of EBV-encoded genes were screened by reverse transcription- polymerase chain reaction (RT-PCR), and confirmed by Southern blot hybridization. The expression of EBV-related antigens was examined by immunostaining using paraffin-embedded tissue sections and cell pellets of EBV-positive cell lines. Our study demonstrated that all samples from the patients contained EBV nuclear antigen (EBNA)-1 mRNA which was transcribed using the Q promoter, whereas both the Q promoter and another upstream promoter (Cp/Wp) were used in EBV-positive cell lines, B95.8, Raji and Jiyoye. Latent membrane protein-1 (LMP-1) mRNA was detected in seven of eight patients and all cell lines, whereas EBNA-2 transcripts were found only in the cell lines. Immunostaining showed no LMP-1, EBNA-2 or ZEBRA antigens in the paraffin-embedded tissue sections, although they were positive in the cell line cells. Latent BHRF1 transcripts encoding bcl-2 homologue and BCRF1 transcripts encoding viral interleukin (vIL)-10 were detected in one and two of eight patients, respectively. A patient with NK-cell lymphoma expressing both transcripts died of rapid progression of the illness. Our results indicate that the restricted expression of the latency-associated EBV genes and the production of vIL-10 and bcl-2 homologue may favour tumour growth, evading the host immune surveillance.

Original languageEnglish
Pages (from-to)920-925
Number of pages6
JournalBritish Journal of Cancer
Volume84
Issue number7
DOIs
Publication statusPublished - Apr 6 2001

Fingerprint

Natural Killer T-Cells
Epstein-Barr Virus Infections
T-Cell Lymphoma
Human Herpesvirus 4
Interleukin-10
Skin
Epstein-Barr Virus Nuclear Antigens
Cell Line
Natural Killer Cells
Paraffin
Membrane Proteins
Phenotype
Satellite Viruses
Nuclear RNA
Antigens
Messenger RNA
Viral Genes
Terminal Repeat Sequences
DNA
Southern Blotting

Keywords

  • Bcl-2 homologue
  • EBNA
  • Epstein-Barr virus
  • Latency
  • LMP
  • NK/T-cell lymphomas
  • Viral IL-10

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas. / Xu, Z. G.; Iwatsuki, K.; Oyama, N.; Ohtsuka, M.; Satoh, M.; Kikuchi, S.; Akiba, H.; Kaneko, F.

In: British Journal of Cancer, Vol. 84, No. 7, 06.04.2001, p. 920-925.

Research output: Contribution to journalArticle

Xu, ZG, Iwatsuki, K, Oyama, N, Ohtsuka, M, Satoh, M, Kikuchi, S, Akiba, H & Kaneko, F 2001, 'The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas', British Journal of Cancer, vol. 84, no. 7, pp. 920-925. https://doi.org/10.1054/bjoc.2000.1687
Xu, Z. G. ; Iwatsuki, K. ; Oyama, N. ; Ohtsuka, M. ; Satoh, M. ; Kikuchi, S. ; Akiba, H. ; Kaneko, F. / The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas. In: British Journal of Cancer. 2001 ; Vol. 84, No. 7. pp. 920-925.
@article{c0a59573fbfa4ecfb48105aae3efe1e6,
title = "The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas",
abstract = "The nasal type, extranodal natural killer or T(NK/T)-cell lymphoma is usually associated with latent Epstein-Barr virus (EBV) infection. In order to elucidate the EBV gene expression patterns in vivo, we examined eight patients with cutaneous EBV-related NK/T-cell lymphomas, including six patients with a NK-cell phenotype and two patients with a T-cell phenotype. The implication of EBV in the skin lesions was determined by the presence of EBV-DNA, EBV-encoded nuclear RNA (EBER) and a clonality of EBV-DNA fragments containing the terminal repeats. Transcripts of EBV-encoded genes were screened by reverse transcription- polymerase chain reaction (RT-PCR), and confirmed by Southern blot hybridization. The expression of EBV-related antigens was examined by immunostaining using paraffin-embedded tissue sections and cell pellets of EBV-positive cell lines. Our study demonstrated that all samples from the patients contained EBV nuclear antigen (EBNA)-1 mRNA which was transcribed using the Q promoter, whereas both the Q promoter and another upstream promoter (Cp/Wp) were used in EBV-positive cell lines, B95.8, Raji and Jiyoye. Latent membrane protein-1 (LMP-1) mRNA was detected in seven of eight patients and all cell lines, whereas EBNA-2 transcripts were found only in the cell lines. Immunostaining showed no LMP-1, EBNA-2 or ZEBRA antigens in the paraffin-embedded tissue sections, although they were positive in the cell line cells. Latent BHRF1 transcripts encoding bcl-2 homologue and BCRF1 transcripts encoding viral interleukin (vIL)-10 were detected in one and two of eight patients, respectively. A patient with NK-cell lymphoma expressing both transcripts died of rapid progression of the illness. Our results indicate that the restricted expression of the latency-associated EBV genes and the production of vIL-10 and bcl-2 homologue may favour tumour growth, evading the host immune surveillance.",
keywords = "Bcl-2 homologue, EBNA, Epstein-Barr virus, Latency, LMP, NK/T-cell lymphomas, Viral IL-10",
author = "Xu, {Z. G.} and K. Iwatsuki and N. Oyama and M. Ohtsuka and M. Satoh and S. Kikuchi and H. Akiba and F. Kaneko",
year = "2001",
month = "4",
day = "6",
doi = "10.1054/bjoc.2000.1687",
language = "English",
volume = "84",
pages = "920--925",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "7",

}

TY - JOUR

T1 - The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas

AU - Xu, Z. G.

AU - Iwatsuki, K.

AU - Oyama, N.

AU - Ohtsuka, M.

AU - Satoh, M.

AU - Kikuchi, S.

AU - Akiba, H.

AU - Kaneko, F.

PY - 2001/4/6

Y1 - 2001/4/6

N2 - The nasal type, extranodal natural killer or T(NK/T)-cell lymphoma is usually associated with latent Epstein-Barr virus (EBV) infection. In order to elucidate the EBV gene expression patterns in vivo, we examined eight patients with cutaneous EBV-related NK/T-cell lymphomas, including six patients with a NK-cell phenotype and two patients with a T-cell phenotype. The implication of EBV in the skin lesions was determined by the presence of EBV-DNA, EBV-encoded nuclear RNA (EBER) and a clonality of EBV-DNA fragments containing the terminal repeats. Transcripts of EBV-encoded genes were screened by reverse transcription- polymerase chain reaction (RT-PCR), and confirmed by Southern blot hybridization. The expression of EBV-related antigens was examined by immunostaining using paraffin-embedded tissue sections and cell pellets of EBV-positive cell lines. Our study demonstrated that all samples from the patients contained EBV nuclear antigen (EBNA)-1 mRNA which was transcribed using the Q promoter, whereas both the Q promoter and another upstream promoter (Cp/Wp) were used in EBV-positive cell lines, B95.8, Raji and Jiyoye. Latent membrane protein-1 (LMP-1) mRNA was detected in seven of eight patients and all cell lines, whereas EBNA-2 transcripts were found only in the cell lines. Immunostaining showed no LMP-1, EBNA-2 or ZEBRA antigens in the paraffin-embedded tissue sections, although they were positive in the cell line cells. Latent BHRF1 transcripts encoding bcl-2 homologue and BCRF1 transcripts encoding viral interleukin (vIL)-10 were detected in one and two of eight patients, respectively. A patient with NK-cell lymphoma expressing both transcripts died of rapid progression of the illness. Our results indicate that the restricted expression of the latency-associated EBV genes and the production of vIL-10 and bcl-2 homologue may favour tumour growth, evading the host immune surveillance.

AB - The nasal type, extranodal natural killer or T(NK/T)-cell lymphoma is usually associated with latent Epstein-Barr virus (EBV) infection. In order to elucidate the EBV gene expression patterns in vivo, we examined eight patients with cutaneous EBV-related NK/T-cell lymphomas, including six patients with a NK-cell phenotype and two patients with a T-cell phenotype. The implication of EBV in the skin lesions was determined by the presence of EBV-DNA, EBV-encoded nuclear RNA (EBER) and a clonality of EBV-DNA fragments containing the terminal repeats. Transcripts of EBV-encoded genes were screened by reverse transcription- polymerase chain reaction (RT-PCR), and confirmed by Southern blot hybridization. The expression of EBV-related antigens was examined by immunostaining using paraffin-embedded tissue sections and cell pellets of EBV-positive cell lines. Our study demonstrated that all samples from the patients contained EBV nuclear antigen (EBNA)-1 mRNA which was transcribed using the Q promoter, whereas both the Q promoter and another upstream promoter (Cp/Wp) were used in EBV-positive cell lines, B95.8, Raji and Jiyoye. Latent membrane protein-1 (LMP-1) mRNA was detected in seven of eight patients and all cell lines, whereas EBNA-2 transcripts were found only in the cell lines. Immunostaining showed no LMP-1, EBNA-2 or ZEBRA antigens in the paraffin-embedded tissue sections, although they were positive in the cell line cells. Latent BHRF1 transcripts encoding bcl-2 homologue and BCRF1 transcripts encoding viral interleukin (vIL)-10 were detected in one and two of eight patients, respectively. A patient with NK-cell lymphoma expressing both transcripts died of rapid progression of the illness. Our results indicate that the restricted expression of the latency-associated EBV genes and the production of vIL-10 and bcl-2 homologue may favour tumour growth, evading the host immune surveillance.

KW - Bcl-2 homologue

KW - EBNA

KW - Epstein-Barr virus

KW - Latency

KW - LMP

KW - NK/T-cell lymphomas

KW - Viral IL-10

UR - http://www.scopus.com/inward/record.url?scp=0035815216&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035815216&partnerID=8YFLogxK

U2 - 10.1054/bjoc.2000.1687

DO - 10.1054/bjoc.2000.1687

M3 - Article

C2 - 11286472

AN - SCOPUS:0035815216

VL - 84

SP - 920

EP - 925

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 7

ER -